NM_001367561.1:c.1292G>C
Variant summary
Our verdict is Likely benign. The variant received -1 ACMG points: 0P and 1B. BP4
The NM_001367561.1(DOCK7):c.1292G>C(p.Gly431Ala) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.000145 in 1,589,528 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Synonymous variant affecting the same amino acid position (i.e. G431G) has been classified as Likely benign.
Frequency
Consequence
NM_001367561.1 missense
Scores
Clinical Significance
Conservation
Publications
- genetic developmental and epileptic encephalopathyInheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
- developmental and epileptic encephalopathy, 23Inheritance: AR Classification: STRONG, MODERATE, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics, Orphanet, G2P
Genome browser will be placed here
ACMG classification
Our verdict: Likely_benign. The variant received -1 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
DOCK7 | NM_001367561.1 | c.1292G>C | p.Gly431Ala | missense_variant | Exon 12 of 50 | ENST00000635253.2 | NP_001354490.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.000171 AC: 26AN: 152040Hom.: 0 Cov.: 32 show subpopulations
GnomAD2 exomes AF: 0.0000814 AC: 19AN: 233282 AF XY: 0.0000712 show subpopulations
GnomAD4 exome AF: 0.000142 AC: 204AN: 1437488Hom.: 0 Cov.: 31 AF XY: 0.000130 AC XY: 93AN XY: 714430 show subpopulations
GnomAD4 genome AF: 0.000171 AC: 26AN: 152040Hom.: 0 Cov.: 32 AF XY: 0.000189 AC XY: 14AN XY: 74250 show subpopulations
ClinVar
Submissions by phenotype
Developmental and epileptic encephalopathy, 23 Uncertain:2Benign:1
This sequence change replaces glycine, which is neutral and non-polar, with alanine, which is neutral and non-polar, at codon 431 of the DOCK7 protein (p.Gly431Ala). This variant is present in population databases (rs201785444, gnomAD 0.02%). This variant has not been reported in the literature in individuals affected with DOCK7-related conditions. ClinVar contains an entry for this variant (Variation ID: 578368). Algorithms developed to predict the effect of missense changes on protein structure and function (SIFT, PolyPhen-2, Align-GVGD) all suggest that this variant is likely to be tolerated. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
- -
The homozygous variant was found in patients diagnosed with another variant in a different gene, with no symptoms related to the gene containing the homozygous variant. -
not provided Uncertain:2
- -
In silico analysis supports that this missense variant does not alter protein structure/function; Has not been previously published as pathogenic or benign to our knowledge -
Inborn genetic diseases Uncertain:1
The c.1292G>C (p.G431A) alteration is located in exon 12 (coding exon 12) of the DOCK7 gene. This alteration results from a G to C substitution at nucleotide position 1292, causing the glycine (G) at amino acid position 431 to be replaced by an alanine (A). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at